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Bcl10 Is Involved in t(1;14)(p22;q32) of MALT
B Cell Lymphoma and Mutated in Multiple Tumor Types
nearly all cases of Burkitt's lymphoma (Magrath, 1990).
Similarly, Bcl2, which suppresses several forms of apo-
ptosis, was cloned from the t(14;18)(q32;q21) found in
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Vaandrager et al., 1996). Translocation to the Ig loci mayRifat Hamoudi,² Peter G. Isaacson,§
result not only in deregulated expression of the incomingand Martin J. S. Dyer*#
oncogene, due in part to the proximity of potent B cell*Academic Department of Haematology
transcriptional enhancers within the Ig loci (Jain et al.,and Cytogenetics
1993), but also in mutations due to the action of the²Cancer Gene Cloning Centre
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B cell lymphomas of mucosa-associated lymphoidUnited Kingdom
tissue (MALT lymphomas) are the commonest form of§Department of Histopathology
lymphoma arising in extranodal sites, in most casesUniversity College London Medical School
arising in the gastric mucosa (Isaacson and Spencer,University Street
1995). They may be either high or low grade. It is likelyLondon, WC1E 6JJ
that most high-grade cases represent transformation ofUnited Kingdom
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grade MALT lymphoma is an indolent disease and is
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often preceded by either chronic inflammation or auto-
University of Leuven immune disease such as Hashimoto's thyroiditis in thy-
Belgium roid and chronic Helicobacter pylori infection in stom-
ach. The etiological link between low-grade gastric
MALT lymphoma and lymphoid reaction to H. pylori in-
Summary fection has been demonstrated by the regression of
some cases with antibiotic therapy alone (Wotherspoon
MALT B cell lymphomas with t(1;14)(p22;q32) showed et al., 1993).
a recurrent breakpoint upstream of the promoter The molecular events leading to H. pylori±indepen-
dent growth and high-grade transformation of MALTof a novel gene, Bcl10. Bcl10 is a cellular homolog of
lymphoma are unknown. Cytogenetic studies of low-the equine herpesvirus-2 E10 gene: both contain an
grade cases have identified abnormalities of chromo-amino-terminal caspase recruitment domain (CARD)
some 1p22, in particular translocation t(1;14)(p22;q32),homologous to that found in several apoptotic mole-
as uncommon but recurrent events (Wotherspoon etcules. Bcl10 and E10 activated NF-kB but caused apo-
al., 1992). Cases with 1p22 abnormalities were moreptosis of 293 cells. Bcl10 expressed in a MALT lym-
aggressive than typical cases of low-grade disease andphoma exhibited a frameshift mutation resulting in
also grew in vitro without additional stimuli (Hussell ettruncation distal to the CARD. Truncated Bcl10 acti-
al., 1993 and M-Q. D. et al., unpublished observations).vated NF-kB but did not induce apoptosis. Wild-type
We have cloned a t(1;14)(p22;q32) translocation break-Bcl10 suppressed transformation, whereas mutant
point from a case of low-grade MALT lymphoma. Thisforms had lost this activity and displayed gain-of-func-
was a recurrent breakpoint adjacent to a novel gene,tion transforming activity. Similar mutations were de-
Bcl10, that exhibited an amino-terminal caspase recruit-tected in other tumor types, indicating that Bcl10 may
ment domain, or CARD (Hofmann et al., 1997), similar tobe commonly involved in the pathogenesis of human
that found in apoptotic regulatory and effector proteinsmalignancy.
including RAIDD, (Duan and Dixit, 1997), RICK/RIP2/
CARDIAK (Inohara et al., 1998; McCarthy et al., 1998;
Introduction Thome et al., 1998), and ARC (Koseki et al., 1998). Unex-
pectedly, Bcl10 was proapoptotic in 293 cells. However,
The lymphomas of mature B cells are a heterogeneous a MALT lymphoma with the t(1;14)(p22;q32) showed a
group of disorders that frequently exhibit chromosomal Bcl10 frameshift mutation resulting in truncation beyond
translocations targeted to the immunoglobulin (Ig) loci. the CARD. Unlike the wild-type protein, truncated mu-
These translocations may be specific for histologically tants failed to induce apoptosis and enhanced transfor-
defined subtypes of disease and involve genes control- mation by cooperating oncogenes. These data suggest
ling cell proliferation and apoptosis. Thus, transloca- that truncating mutations of Bcl10 may confer a survival
tions involving the Myc gene with the Ig loci are seen in benefit to MALT B cell lymphomas and may allow pro-
gression to antigen-independent proliferation. Truncat-
ing Bcl10 mutations similar or identical to those ob-# To whom correspondence should be addressed (e-mail: mdyer@
icr.ac.uk). served in the MALT lymphoma were seen in other tumor
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Figure 1. Molecular Cloning of t(1;14)(p22;q32)
Translocation Breakpoint in a Case of Low-
Grade MALT Lymphoma
(A) Gel electrophoresis of LDI-PCR products
from PstI-digested DNA together with sche-
matic representations of the two rearrange-
ments. LDI-PCR yielded products of 5.5 and
0.7 kb. Sequence analysis of these revealed
a productive IgVDJ rearrangement on the
shorter allele and novel sequences upstream
of JH6 in the other. A single copy probe
(0.27EX) was used to isolate cosmid clones
that were mapped back to 1p22 by FISH,
demonstrating that this allele represented the
translocation breakpoint. Open box repre-
sents the region of identity with ESTs. Orien-
tation of the open reading frame revealed a
head-to-head configuration of Bcl10 and IgH.
Bg, BglII; E, EcoRI; H, HindIII; P, PstI; X, XbaI.
(B) Southern blot analysis of MALT lympho-
mas with t(1;14)(p22;q32). Left hand panel:
Case G0186 (from which the breakpoint was
cloned) showed biallelic IgJH rearrangement
with one allele comigrating with rearranged
Bcl10 probe 0.27EX, indicating that no arti-
facts had been introduced during LDI-PCR.
Right hand panel: Case G0262 showed one
IgJH rearrangement. This represented a pro-
ductive VDJ rearrangement (data not shown);
we assume that this case had undergone
translocation to a downstream switch region
rather than to IgJH. This case showed re-
arrangements with the Bcl10 probe in multi-
ple digests, indicating a clustering of break-
points within the same region of the Bcl10
gene. ªNº denotes normal and ªTº tumor DNA
samples. Arrowheads denote rearranged
fragments.
(C) FISH image of MALT lymphoma case with
t(1;14)(p22;q32). Cosmid Ig3/64 containing
sequences for IgJH and Cm was labeled red,
and CEPH YAC 929e1 containing Bcl10 was
labeled green. The Bcl10 YAC was split by
the translocation and colocalized with IgH on
the derivative chromosome 14.
types, indicating that Bcl10 may be involved in the not shown). In case G0186, JH and 1p22 probes showed
comigration of rearranged bands, indicating that no ma-pathogenesis of several human malignancies.
jor artifacts had been introduced during the LDI-PCR
(Figure 1B). Further FISH experiments showed a breakResults
within a derived Bcl10 YAC clone (Figure 1C), and South-
ern blots using 1p22 probes derived from the breakpointCloning of the t(1;14)(p22;q32) Breakpoint
and Identification of Bcl10 showed rearrangement in all three cases, indicating that
this was a recurrent breakpoint in MALT lymphoma (Fig-Three cases of low-grade MALT lymphoma with t(1;14)
(p22;q32) were studied. On the assumption that the ure 1B).
To identify the involved gene on chromosome 1p22,translocation breakpoint involved the IgH locus directly,
both IgJH alleles from one case (G0186) were cloned the 5.5 kb PstI fragment was sequenced and showed a
255 bp region 4.6 kb upstream of JH6 with 100% identityusing long-distance inverse PCR (LDI-PCR; Willis et al.,
1997, 1998). Two products of 700 and 5500 base pairs to EST clone # 1184134. Genomic sequences immedi-
ately 59 of this potential exon had features of a promoter(bp) were obtained (Figure 1A). The sequence of the
700 bp allele showed a productive and mutated VH3- site and contained many potential protein-binding sites
(accession number AJ006290). These data indicated a20 rearrangement (data not shown), while the other allele
contained sequences with no homologies to any known head-to-head configuration of the translocation (Fig-
ure 1A).sequences beyond JH6. To confirm that this repre-
sented the translocation breakpoint, cosmids were iso- By a combination of DNA±database searching using
dbEST (www.ncbi.nlm.nih.gov/dbEST) and reverselated using single copy probes from this region and
mapped back to chromosome 1p22 on normal meta- transcription PCR methods, the full-length coding se-
quence of this gene was determined (accession numberphases by fluorescent in situ hybridization (FISH; data
Bcl10 in Malignancy
37
Figure 2. Sequence of Bcl10
(A) Nucleotide and predicted amino acid sequences of Bcl10. Exon/intron boundaries are indicated. Mononucleotide runs mutated in malignan-
cies are underlined.
(B) Amino acid sequence alignment of human and mouse Bcl10 and the EHV-2 open reading frame E10. Bcl10 and E10 contain highly
homologous CARDs but diverge thereafter. The published sequence of EHV-2 ORF E10 (accession U20824; Telford et al., 1995) contains a
frameshift at codon 143, predicting a protein of 210 amino acids. The corrected sequence predicting a protein of 311 amino acids is shown.
Black boxes indicate $50% amino acid identity; gray shading indicates $50% similarity through conservative amino acid substitutions.
(C) Amino acid alignment of CARD-containing proteins. The most homologous proteins to Bcl10 and E10 were RAIDD and procaspase-2.
AJ006288; Figure 2A). This was predicted to encode a Bcl10 Expression in Normal and Malignant Tissues
Bcl10, expressed as a transcript of 4.2 kb, was observed233 amino acid protein with a molecular weight of 26.2
kDa. Due to the direct involvement of this gene in three in all normal and malignant tissues examined (data not
shown). To examine the expression in mature B cellscases of MALT lymphoma with t(1;14)(p22;q32), we have
termed this gene Bcl10 (B cell lymphoma/leukemia 10). within normal lymphoid tissue, in situ hybridization (ISH)
was performed. Levels of Bcl10 expression were highThe mouse Bcl10 gene was also cloned and se-
quenced (AJ006289); this was 91% identical to the hu- within germinal centers but much lower within the man-
tle zones of normal lymphoid follicles (Figure 3). MALTman gene (Figure 2B). BLAST searches revealed that
Bcl10 contained a region with strong homology (47% lymphomas are thought to arise from marginal zone
cells; marginal zone cells from normal Peyer's patchesidentity and 24.7% similarity over 97 amino acids) to an
EHV-2 open reading frame (ORF), E10; Bcl10 therefore showed an intermediate level of Bcl10 expression. Insuf-
ficient suitable material was available to study the ex-appeared to be a cellular homolog of E10. This homology
was limited principally to the CARD (Figure 2B). Bcl10 pression of Bcl10 in any of the three cases with
t(1;14)(p22;q32) by Northern blot, but all three casesalso had weaker homologies with the amino-terminal
CARD of RAIDD (25% identity and 25% similarity); ho- expressed Bcl10 mRNA, as assessed by ISH (Figure 3).
However, all cases of B cell malignancy examined bymologies with other molecules involved in apoptosis
that also contain CARDs were lower (Figure 2C). Distal either Northern blot or by ISH expressed high amounts
of Bcl10 irrespective of whether they exhibited t(1;14)to the CARD, Bcl10 showed no significant homologies
with any other known proteins. Similarly, the homology (p22;q32), indicating that, like Bcl2 (Zutter et al., 1991)
and Bcl6 (Cattoretti et al., 1995), mechanisms other thanwith E10 was also much lower in this domain.
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clones. In three clones (designated M106), this was the
only mutation present. The consequence of this frame-
shift mutation was to induce premature termination of
the ORF, resulting in a predicted protein of 168 amino
acids (Figure 5A). In the most heavily mutated clone
(M114), there were four other mutations, including a
deletion of 11 amino acids (116±126) due to loss of a
splice acceptor site at the boundary of the third coding
exon (Figure 5B and see below), as well as two other
point mutations within the CARD and another at codon
100. Most of the point mutations in this case of MALT
lymphoma were A→G transitions consistent with IgVH
gene somatic hypermutation. No mutations were de-
tected in Bax and the TGFb-RII genes that also contain
mononucleotide repeats and are frequently mutated in
diseases that exhibit microsatellite mutator phenotype
(data not shown).
Figure 3. In Situ Hybridization for Bcl10 mRNA
In reactive human Peyer's patch (left), high levels of Bcl10 expres-
sion were seen in the follicle center cells (FC) but not in mantle zone Truncated Bcl10 Retains NF-kB Activation
cells (MZ). Intermediate levels of Bcl10 expression were observed but Does Not Induce Apoptosis
in the marginal zone cells (MGZ), the presumed cell of origin of To assess any possible differences between the wild-
MALT lymphoma. Glandular epithelial cells (G) were negative for
type and truncated Bcl10 mutants, both M106 and M114Bcl10. In gastric MALT lymphoma with t(1;14)(p22;q32) (right), abun-
were transfected into 293 cells. Both M106 and M114dant Bcl10 mRNA was detected in the tumor cells but not in the
activated NF-kB to a level comparable to that seen withgastric gland epithelial cells.
the wild-type protein (Figure 4E). However, neither mu-
tant clone exhibited significant apoptosis in this assay
(Figures 4C and 5C). These data indicate that the full-translocation may result in high-level Bcl10 expression
length Bcl10 molecule was necessary for the apoptotic(data not shown).
function but not NF-kB activation. Cotransfection of ei-
ther M106 or M114 Bcl10 mutants with wild-type Bcl10Bcl10 Induces Apoptosis and NF-kB Activation
was also performed; coexpression of either truncatedBy analogy with the t(14;18)(q32;q21) involving the Bcl2
mutant did not significantly abrogate wild-type Bcl10-gene in follicular B cell non-Hodgkin lymphoma, and
induced apoptosis (Figure 4G).from the predicted functions of E10 (Hofmann et al.,
1997), we anticipated that both Bcl10 and E10 proteins
would be antiapoptotic. However, both induced apopto- Mutation Activates a Transforming
sis when transfected into 293 cells (Figure 4C) and in- Function in Bcl10
duced activation of NF-kB (Figures 4D and 4E); compa- Some proteins that induce apoptosis function as sup-
rable apoptosis was seen when Bcl10 was transfected pressors of transformation (Eliyahu et al., 1989; Yin et
into other cell lines, including COS-7 and HeLa (data al., 1997). The observation that Bcl10 induced apoptosis
not shown). Bcl10-induced apoptosis was inhibited by raised the possibility that it might also possess transfor-
both z-VAD-fmk and by cotransfection of CrmA (Figures mation suppressor properties. To address this issue,
4C and 4G). Comparison with other apoptotic mediators, the effect of Bcl10 expression was determined in the
such as TNFR1, indicated that Bcl10 and E10 were only primary rat embryo fibroblast (REF) system. In this
weakly proapoptotic (Figure 4C). Furthermore, IL3- assay, nuclear oncoproteins such as adenovirus E1a,
dependent BA/F3 B cell lines stably expressing exoge- papillomavirus E7, and some mutant p53 proteins coop-
nous Bcl10 were isolated, and unlike Bcl2, expression erate with an activated ras oncogene to induce morpho-
of Bcl10 did not promote survival in the absence of IL3 logical transformation (Crook et al., 1994). Such transfor-
and did not protect significantly from apoptosis induced mation is suppressed efficiently by some human tumor
by a combination of TNFa and cycloheximide (data not suppressor proteins such as wild-type p53. We therefore
shown). performed transfections in which primary REFs received
a transforming combination of oncoproteins (e.g., E1a 1
ras, HPVE7 1 ras, mutant p53 1 ras) together with plas-Bcl10 Mutations in MALT Lymphoma
with t(1;14)(p22;q32) mids encoding either wild-type Bcl10, E10, or tumor-
derived Bcl10 mutants. Transfection of each cooperat-Given that wild-type Bcl10 induced apoptosis, we ex-
amined case G0186 from which the translocation ing pair of oncogenes, in the absence of exogenous
Bcl10 expression, generated numerous transformedbreakpoint was cloned for mutations within the Bcl10
ORF. Using RT-PCR and DNA sequencing of cloned colonies that could be readily propagated as cell lines.
Cotransfection of wild-type Bcl10 significantly reducedPCR products, 18 clones were sequenced. Two were
normal, while 16 showed mutations within the coding the numbers of transformed colonies generated by each
pair of cooperating oncogenes (Table 1). In contrast,region of Bcl10. Insertion of an additional thymidine into
a mononucleotide run of seven consecutive thymidines cotransfection with either of two tumor-derived mutants,
M106 or M114, or with E10, markedly enhanced the(nucleotides 493 to 499) was observed in 10/16 mutated
Bcl10 in Malignancy
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Figure 4. Bcl10 and E10 Induce Apoptosis
and Activate NF-kB
Apoptosis assay: 293 cells were transfected
with 1 mg of the indicated expression con-
structs and 0.25 mg of pcDNA3.1 b-gal. Forty-
eight hours after transfection, cells were
stained with X-gal and at least 300 blue cells
counted per well.
(A) Photomicrograph of cells transfected with
pcDNA3.1.
(B) Photomicrograph of cells transfected with
pcDNA3.1 Bcl10 showing cells with apoptotic
morphology.
(C) Apoptosis is induced by Bcl10 and E10 but
not by the carboxy-terminal region of Bcl10
or by tumor-associated truncation mutants.
Data (6 SD) are shown as the percentage
of morphologically apoptotic cells for three
independent transfections. Where indicated,
25 mM z-VAD-fmk was added 6 hr post-
transfection.
(D and E) NF-kB reporter assay: 293 cells
were transfected with the indicated amounts
of the expression construct, 0.25 mg pTK-
cSPAP reporter with (filled boxes) or without
(open boxes) the NF-kB response element,
and 0.25 mg of pcDNA3.1 b-gal, to a total of
1.5 mg of DNA. Forty-eight hours after trans-
fection, absorbance at 405 nm relative to vec-
tor-transfected cells was measured. Results 6
SD for experiments performed in triplicate.
(F) Western blot analysis of transfected 293
cells. Cell lysates from cells transfected with
the indicated plasmids were immunoblotted
with monoclonal antibody to myc.
(G) Truncated Bcl10 does not significantly in-
hibit wild-type Bcl10-induced apoptosis. 293
cells were transfected with wild-type Bcl10 in
the presence of either M106 or M114 mutant
clones and apoptosis assessed. Comparable
levels of expression of the wild-type and mu-
tant proteins were observed as shown in the
Western blot.
number of transformed colonies in each case and We therefore sought Bcl10 mutations in a panel of fresh
lymphoma cases and in cell lines derived from variouscaused the transformed colonies to appear earlier.
Moreover, cotransfection of either Bcl10 mutant with human malignancies. A panel of archival lymphoma
cases were studied by PCR-SSCP, and in some cases,ras alone revealed that each mutant had itself acquired
a weak but reproducible ability to cooperate with ras. the abnormal SSCP bands were excised, reamplified,
and sequenced.
PCR-SSCP analysis of a panel of 135 cases of B cellBcl10 Mutations Are Found in Multiple
Human Tumor Types and 20 cases of T cell lineage lymphoma of various
histological subtypes revealed abnormal migrating bandsNo RNA samples were available from the other two
cases of MALT lymphoma with t(1;14)(p22;q32). To in 70 (45%); abnormal PCR-SSCP bands were observed
in all lymphoma subtypes (M. J. S. D. et al., in prepara-search for Bcl10 mutations in these cases, the genomic
sequence and the exon/intron structure of the Bcl10 tion). A representative gel along with the derived se-
quences from one case of follicular B cell lymphomacoding region were determined and PCR primers de-
signed to amplify the three coding exons from paraffin that showed two deletions within the coding region of
exon 3 is shown in Figure 6B. The sequence abnormali-sections. Mutations in all three cases with t(1;14)(p22;
q32) were sought by PCR-SSCP. All showed abnormal ties in ten cases of MALT and follicular non-Hodgkin
lymphoma in which the abnormal PCR-SSCP band wasmigrating bands consistent with mutation; different sec-
tions from different histological blocks from the same excised, successfully reamplified, and sequenced are
shown in Table 2. Truncating Bcl10 mutations were de-tumor showed different bands, indicating that in all three
cases Bcl10 mutation was ongoing (Figure 6A). tected in both subtypes of lymphoma in the absence of
1p22 chromosomal translocation.Chromosome 1p22 is also a common site of deletions
and translocations in subtypes of lymphoma other than Subsequently, 87 cell lines derived from patients with
other forms of malignancy were examined either by se-MALT, as well as a wide range of solid tumors (Tilly et
al., 1994; Mertens et al., 1997; Thangavelu et al., 1997). quencing cDNA clones (n 5 6) or by genomic PCR of
Cell
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Figure 6. PCR-SSCP Analysis of Bcl10 Mutations
(A) Ongoing mutations in a case of MALT lymphoma with
t(1;14)(p22;q32). Exons 2.2 (left panel) and 3.2 (right panel) of a
case of MALT lymphoma with t(1;14)(p22;q32) (case G0262) were
amplified from different sections taken from different blocks of the
same tumor and subject to SSCP. ªNº denotes normal DNA, lanes
Figure 5. Bcl10 Truncation Mutants 1±5 different samples from the same tumor. Arrowheads denote
(A) An abnormality in MALT lymphoma mutants M106 and M114 in abnormal bands; note that these are only present in some tumor
cell lines M25, Mero82 (mesothelioma), and Tera2 (teratoma) was samples and not all.
the insertion of a thymidine in a mononucleotide run of seven thymi- (B) Two internal Bcl10 deletions in a case of follicular B cell lym-
dines at nucleotides 493±499, resulting in truncation at codon 168. phoma (case G0109). A PCR-SSCP gel showing two normal controls
(B) Bcl10 exon 2/3 splice site abnormalities. MALT mutant 114 had and case G0109 with abnormally migrating bands is shown. Abnor-
an 11 amino acid in-frame deletion at the start of exon 3. Mesotheli- mal bands labeled ªaº and ªbº were excised, reamplified, and se-
oma line M25a had a 16 base pair deletion at the start of exon 3, quenced. The sequences are shown in the right-hand panel. Band
causing a frameshift and a truncated protein of 141 amino acids. ªaº represented a 17 bp deletion, whereas band ªbº represented
Closed triangles, normal splice sites; open triangles, new splice a 28 bp deletion occurring within coding exon 3 and resulting in
sites. frameshifts within the Bcl10 coding sequence with predicted protein
(C) Structure of wild-type Bcl10 and the two tumor-derived truncated products of 176 and 169 amino acids, respectively.
mutants studied, with phenotypes in apoptosis, NF-kB activation,
and REF transformation assays.
cell precursor ALL cell line MOLT-4, a colonic adenocar-
cinoma cell line, Lovo, and the mesothelioma cell line
M41; these mutations fell within the region encoding theexons 2 and 3 and direct sequencing of the PCR product
CARD and were predicted to result in proteins of 48(n 5 81). As summarized in Table 2, 10/87 cell lines
(insertion) and 69 (deletion) amino acids. Six of the 21showed truncating mutations. The frequency of Bcl10
(28%) mutations in which the results of truncation couldmutation depended on the origin of the derived cell
be predicted exhibited mutations that fell within theline. All three mesothelioma and all three male germ cell
CARD; the remainder fell distal to the CARD and weretumor cell lines exhibited Bcl10 mutation, whereas no
similar to those seen in the MALT lymphoma with themutations within coding exons 2 and 3 were seen in a
panel of 15 breast carcinoma, 11 pancreatic adenocarci-
noma, and 15 lung carcinoma cell lines. Bcl10 mutations
Table 1. Effect of Bcl10 Expression on Transformation of
were seen in 2/25 colonic adenocarcinoma and 2/18 Primary REFs
leukemia and lymphoma cell lines.
Wild-TypeOf the 32 mutations shown in Table 2, 25 represented
Vector Bcl10 E10 M106 M114
frameshift mutations that would result in truncated pro-
ras 0 0 0 6 8tein. Some of these mutations represented deletions
ras 1 pLTRp53cG 12 1 .50 .50 .50resulting in loss of splice donor/acceptor sites at the
ras 1 E1a 16 1 .50 .50 .50
exon 2/3 boundary or in the colon carcinoma cell line, ras 1 p53 234C 6 0 .20 .20 .20
LS513, at the exon 1/2 boundary (Figure 5B), while oth- ras 1 E7 10 0 .50 .20 .20
ers represented internal deletions within exons 2 and
Data shown are number of transformed colonies per plate following3 (Figure 5B). As with the MALT lymphoma with the
transfection with ras and the indicated cooperating oncogenes, with
t(1;14)(p22;q32), insertion of an additional thymidine into or without cotransfection with E10 or wild-type/mutant Bcl10. Data
the mononucleotide run (insT499) was seen in two meso- shown are typical of three transfections. Wild-type Bcl10 sup-
pressed transformation relative to vector, while E10 and both tumor-thelioma and one male germ cell tumor cell lines (Figure
derived mutants, M106 and M114, enhanced transformation by5A). Similarly, insertion or deletion of a single adenine
cooperating oncogenes. The mutants showed weak transforminginto a run of eight consecutive A's was observed in
activity with ras alone.
three cell lines of different cell types, including the T
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Table 2. Bcl10 Mutations in Primary NHL and in Cell Lines Derived from Lymphoid and Solid Tumors
Case No. Coding Predicted Protein Size
Tumor or Cell Line Alteration Exon Codon Mutation Type (Full Length 5 233 aa)
Lymphoid Tumors
MALT lymphoma G0186 M1061 499insT 3 167 Truncation 168 aa
M1141 499insT 3 167 Truncation
94A → G 2 32 lIe → Val 5145A → G 2 49 Arg → Gly 157 aa298A → T 2 100 Thr → Ser
346del33 3 116±126 Splice aberration4
G0193 163insA 2 55 Truncation 61 aa
G0123 345delA 2 115 Truncation 116 aa
G0524 345delA 2 115 Truncation 116 aa
Follicular lymphoma G3018 428insTT 3 143 Truncation 147 aa
G3009 231ins A 2 77 Truncation 96 aa
G0109a2 525del17 3 175±181 Truncation 176 aa
b2 508del28 3 170±180 Truncation 169 aa
G3008 410delA 3 137 Truncation 146 aa
G0206 398insT 3 133 Truncation 139 aa
G3023 637del3 3 210 Del Glu 232 aa
T-ALL Molt-4 136insA 2 46 Truncation 48 aa
Sezary syndrome Hut 78 428delT 3 143 Truncation 146 aa
Solid Tumors
Colonic carcinoma Lovo 136insA 2 46 Truncation 48 aa
LS513 delT 1/2 intron Splice aberration
Mesothelioma M25 a3 346del16 3 116±120 Splice aberration4 141 aa
5b3 499insT 3 167 Truncation 168 aa238G → A 2 80 Asp → Asn
M41 a3 136delA 2 43 Truncation 69 aa
b3 155C → T 2 52 Thr → Ile Full length
Mero82 499insT 3 167 Truncation 168 aa
5Germ cell tumor Tera 1 172C → G 2 58 Arg → Gly Full length653C → T 3 218 Ser → Phe
Tera 2 a3 499insT 3 167 Truncation 168 aa
5b3 274C → T 2 91 Truncation 91 aa58G → A 2 20 Ala → Thr
GCT 44 172C → T 2 58 Truncation 57 aa
Cell lines denoted in italics.
1 Mutants M106 and M114; see Figure 5C.
2 Two independent deletions within coding exon 3 were identified in this tumor (see Figure 6B).
3 cDNA clones containing independent mutations (designated ªaº and ªbº) were identified from these cell lines.
4 See Figure 5B.
t(1;14)(p22;q32). Otherwise, there was no apparent clus- lacked the translocation. In this regard, Bcl10 may be
tering of the point mutations. similar to Bcl2 and Bcl6 where high-level expression
may be seen in many B cell lymphomas irrespective of
whether or not they exhibit Ig translocation (Zutter etDiscussion
al., 1991; Cattoretti et al., 1995).
Bcl10, like a number of proteins involved in the controlWe report the cloning of an apoptotic regulatory gene,
and execution of apoptosis, contained a CARD (Hof-Bcl10, from its direct involvement in the t(1;14)(p22;q32)
mann et al., 1997). This domain has been shown toof low-grade MALT lymphoma. From cytogenetic, FISH,
consist of six tightly packed antiparallel alpha helicesSouthern blot, and PCR experiments, breakpoints within
and is similar in structure to the ªDeath Domainº (Chouthe 59 region of Bcl10 were recurrent but present in only
et al., 1998). CARDs have been found in both pro- anda low percentage of cases (M-Q. D. et al., unpublished
antiapoptotic proteins and mediate homotypic CARDobservations). The Bcl10/IgH translocations left the cod-
interactions between structurally related proteins. Theing region of Bcl10 intact. By analogy with Ig transloca-
CARD of RIP2/CARDIAK was sufficient for the apoptotictions that break either 59 or within the promoter regions
actions of this molecule (McCarthy et al., 1998) as well asof other genes such as Myc, Bcl2, and Bcl6, it would
NF-kB and JNK activation (Thome et al., 1998). However,be anticipated that the t(1;14)(p22;q32) would result in
CARD proteins may have functions other than apopto-either deregulated overexpression of Bcl10 due to the
sis; the prodomain of caspase-2 contains a CARD thatproximity of the Ig transcriptional enhancers and/or
allows nuclear translocation (Colussi et al., 1998).loss of normal regulatory controls. In situ hybridization
Bcl10 is the first CARD protein to be implicated inshowed high-level expression in all three MALT lympho-
malignancy. Its involvement is unusual in two regards.mas with the t(1;14)(p22;q32), but comparable levels of
expression were also seen in other lymphomas that First, there is at present no evidence to suggest that
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overexpression or deregulated expression of the wild- However, coexpression of truncated mutants did not
substantially affect the proapoptotic activity of wild-typetype molecule might confer any survival benefit. Overex-
pression of Bcl10 in 293 cells resulted in apoptosis, Bcl10 under the conditions of our assay. While the possi-
bility of transdominant inhibition cannot be excluded, italthough the extent and rate at which apoptosis was
induced was much less and slower than with death- seems likely that selection is for the loss of apoptotic
activity and concomitant gain of proproliferative func-signaling molecules such as TNFR1. Consistent with this
was the efficient suppression of transformation of REFs tion in the truncated mutants rather than for abrogation
of wild-type activity. In this regard, the mutants displayby wild-type Bcl10. In contrast, although E10 induced
a comparable degree of apoptosis as Bcl10 in 293 cells, some functional similarity to some p53 mutants, which,
although unable to inhibit transdominantly the apoptoticin the REF assay it behaved like the Bcl10 mutants and
markedly enhanced the number of transformed colo- activity of the wild-type protein, are nevertheless fre-
quently selected in a wide range of human cancers,nies. The biochemical reasons underlying this difference
between wild-type Bcl10 and E10 are not known, but B presumably as a result of their proproliferative activities
(Gualberto et al., 1998).cell proliferation induced by E10 might allow EHV-2 viral
persistence. Finally, Bcl10 abnormalities were shown to be present
in several subtypes of lymphoma other than MALT. InSecond, Bcl10 appears to be unusually susceptible
to mutation. These mutations principally consisted of follicular lymphoma, abnormalities of chromosome 1p22
have been associated with rapid progression and a pooreither nucleotide insertion or deletion resulting in protein
truncation, in most cases distal to the CARD. Interest- prognosis (Tilly et al., 1994). However, Bcl10 mutations
did not appear to be limited to malignancies of theingly, the truncating mutation common to 10/16 mutated
Bcl10 clones observed in the MALT lymphoma with the lymphoid lineages. Chromosome 1p22 has been shown
to be consistently deleted in several other tumor types,t(1;14)(p22;q32), insertion T 499, was also detected in
both mesothelioma and male germ cell tumor cell lines. including 80% of mesothelioma (Lee et al., 1996) and
40% of male germ cell tumors (Mathew et al., 1994). SoAll three cases of MALT lymphoma with t(1;14)(p22;q32)
exhibited Bcl10 mutation, and it appeared that this pro- far, our analysis of these diseases has been restricted
to derived cell lines. However, given the high frequencycess was ongoing. Ongoing mutation is a feature of
productively rearranged IgVH genes after a B cell has of Bcl10 mutations in these, but not other cell lines, it
seems unlikely that Bcl10 is mutated solely as a conse-encountered antigen, resulting in affinity maturation of
antibody, but has also been seen in other genes in B quence of prolonged in vitro culture. Bcl10 may be the
target gene for the chromosome 1p22 deletions in acell malignancies (Albert et al., 1994; Gutierrez et al.,
1998). Many of the Bcl10 mutations could be ascribed wide range of human malignancy. Both the compro-
mised proapoptotic activity and gain of transformingto the Ig somatic hypermutation mechanism result-
ing in nucleotide transitions, and the function of the activity of human tumor±derived Bcl10 mutants provide
a mechanistic basis for their frequent selection in a widet(1;14)(p22;q32) chromosomal translocation may be to
place the Bcl10 gene under the direct influence of this range of cancers.
mechanism. Detection of Bcl10 abnormalities was hin-
dered by ongoing mutation, and we have found it neces- Experimental Procedures
sary to sequence individual cDNA or genomic clones;
Cloning of t(1;14)(p22;q32) Translocation Breakpointthe frequency of Bcl10 mutations may be significantly
LDI-PCR was performed on high-molecular-weight DNA from aunderestimated by sequencing PCR reactions directly
MALT lymphoma with t(1;14)(p22;q32) as described (Willis et al.,
(T. G. W. et al., unpublished observations). The possible 1997, 1998); 400 ng of DNA was digested with PstI (GIBCO-BRL,
functional significance of the ongoing Bcl10 mutations Gaithersburg, MD) in a volume of 30 ml and then ligated at 158C
are not clear. Both Bcl10 mutants cloned from the MALT overnight in a total volume of 500 ml with 5 U of T4 DNA ligase
(GIBCO-BRL). Ligated DNA was purified using a Qiaquick columnlymphoma with t(1;14)(p22;q32) appeared to have similar
(Qiagen, Hilden, Germany), and 10 ng DNA was amplified with rTthproperties in all assays.
polymerase (GeneAmp, XL: Perkin-Elmer, Foster City, CA) usingThe functional consequences of the Bcl10 mutations
primers for IgJH and reamplified using nested primers. Following
truncating distal to the CARD were the loss of the pro- amplification, the PCR reaction was run on a 0.8% agarose gel and
apoptotic functions with retention of NF-kB activation. the two bands excised. These were purified and A-tailed with 5 U
Expression of NF-kB has been associated with suppres- Taq polymerase (MBI Fermentas, Vilnius, Lithuania), 200 mM dNTPs,
and Taq buffer for 30 min at 728C. The products were cloned intosion of apoptosis and prolongation of survival in many
the Topo TA cloning vector pCR2.1 (Invitrogen, San Diego, CA).systems; NF-kB activation also appears to be an essen-
Sequencing was performed on an Applied Biosystems model 377tial component of several transformation pathways (Wu
sequencer using AmpliTaq DNA polymerase, FS (Perkin-Elmer). Se-
et al., 1996; Mayo et al., 1997; Reuther et al., 1998; quences were analyzed against the NCBI GenBank EST database
Van Antwerp et al., 1998). The dissociation of NF-kB using the BLAST program. cDNA clones corresponding to positive
activation and proapoptotic functions in the truncated ESTs were obtained from the Human Genome Mapping Project
Resource Centre (Cambridge, UK) and sequenced. Southern blot,forms of Bcl10 was consistent with their marked en-
fluorescence in situ hybidization, and Northern blot analysis werehancement of transformation by cooperating onco-
performed as described (Willis et al., 1997, 1998).genes. Whether other Bcl10 truncating mutations that
fall within the CARD have the same phenotype is not
In Situ Hybridizationyet known.
In situ hybridization for Bcl10 mRNA was carried out as described
Transdominant inhibition by tumor-associated mu- (Pan et al., 1997). Briefly, fragments of paraffin sections were de-
tants of wild-type Bcl10-induced apoptosis represents waxed in xylene, washed in ethanol, digested with proteinase K,
fixed in 4% paraformaldehyde/PBS, and hybridized at 508C for 16±18a basis for the selection of Bcl10 mutants in cancer.
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hr with digoxigenin-11-UTP (Boehringer Mannheim, Lewes, UK) la- Following transfection, cells were grown in DMEM/10% FCS in the
presence of 500 mg/ml G418 sulphate (GIBCO). Morphologicallybeled Bcl10 antisense RNA probe. The hybridized sections were
washed, incubated twice in alkaline phosphatase±conjugated sheep transformed colonies were counted after 3 weeks. The following
plasmids were used in the REF assays: pLTRp53cG (Eliyahu et al.,antidigoxigenin for 1 hr, and visualized with 5-bromo-4-chloro-3-
indolyl phosphate/nitro-blue tetrazolium. 1985), pCB6116E7 (Parker et al., 1996), pEJ6.6 (encodes activated
Ha-ras) (Shih and Weinberg, 1982), pCB61p53 234C (Parker et al.,
1996), and pCE (encodes adenovirus E1a) (Schneider et al., 1987).Expression Vectors
Expression clones were amplified by PCR, cloned into the TA cloning
vector pCR2.1 TOPO, and then subcloned in frame into the expres- Cloning and Sequencing of Bcl10 Genomic Fragment
sion vector pcDNA3.1/Myc-His (Invitrogen). The open reading frame One hundred nanograms of normal human genomic DNA was ampli-
of Bcl10 was amplified from a Bcl10 cDNA clone using primers 59- fied with rTth polymerase using primers for the Bcl10 open reading
CCATCTCAGATCTCCACCATG-39 and 59-AAAGTGTCTCGAGCGTG frame 59-CCTCCTCTCCTTCTTCCCCATTACCC-39 and 59-CATTAAA
AACAGTA-39, and the open reading frame for E10 was amplified AATTAAAAGGCAATAAAGTG-39 in a 50 ml reaction at 958C for 1 min
from EHV-2 DNA using primers 59-CCTCCAAGCAGATCTATGGCG- followed by 35 cycles of 958C for 15 s and 688C for 10 min. A 10 kb
39 and 59CAGCAGATATCCCTCCT-39. Both were subcloned into product was subcloned into pCR2.1 TOPO, and automated DNA
pcDNA3.1/Myc-His. The carboxy terminus of Bcl10 (amino acids sequencing was performed using the primers 59-AACATCAAGT
101±233) and mutant MALT lymphoma cDNA clones 106 and 114 AGAAAAAGGGCTGGAAA-39, 59-TTTCCAGCCCTTTTTCTACTTGAT
were amplified by PCR and subcloned into pcDNA3.1/Myc-His. GTT-39, 59-GAGGTTGTTCGTGGCTCCATC-39, and those described
above.
Cell Culture and Transfections
293, COS-7, and HeLa cells were maintained in high glucose Dulbec- PCR-SSCP Studies
co's modified Eagle's medium (DMEM) containing 10% fetal calf DNA samples from frozen and paraffin-embedded tissue blocks
serum, 100 mg/ml penicillin G, and 100 mg/ml streptomycin. For from 155 cases of lymphoma from the Department of Histopathol-
reporter and apoptosis assays, 2 3 105 cells/well were seeded on ogy, University College were studied. The full coding sequence of
6-well (35 mm) dishes. Cells were transfected the following day by the Bcl10 gene was amplified by five different PCR reactions (two
calcium phosphate coprecipitation. Stable G418-resistant transfec- reactions for exons 2 and 3) using the following primer sets: Exon
tants of the mouse IL3-dependent pro±B cell line BA/F3 were gener- 1, 59-GGACCCGGAAGAAGCGCCATCTCC-39 and 59-GATCCTCCTT
ated by electroporation of 107 cells in 400 ml of serum-free medium GTCCTCGGACTC-39 (anticipated product size 5 187 bp); Exon 2.1,
and mixed with 20 mg pcDNA3.1/V5-His plasmid with or without 59-AAGACTGCCAACTAATAGTCACGT-39 and 59-AAGTAGTCTAAC
Bcl10 insert at 250 V and 900 mF. Cells were selected with 1.2 mg/ AATTTTCCAGCCC-39 (200 bp); Exon 2.2, 59-CACTGAAGAAATTTCT
ml G418, seeded at 0.5 cells per well in 96 well plates, and screened TGTCGAACA-39 and 59-AAAAGCATTATTACATTTAAATTAGCTC-39
for exogenous Bcl10 expression. (244 bp); Exon 3.1, 59-TTAACAAGTCACAAGATGGACAGTG-39 and
59-CTAGAACAGGCAAATTCAGAGAAG-39 (262 bp); Exon 3.2, 59-
GGAGAATCCAGCACGACGCCC-39 and 59-CATTAAAAATTAAAAGApoptosis Assays
GCAATAAAGTG-39 (257 bp). PCR was performed on a thermal cycler293, COS-7, and HeLa cells were cotransfected with 1 mg of expres-
(Hybaid, Teddington, UK) using a ªhot startº followed by a ªtouch-sion construct and 0.25 mg pcDNA3.1b-galactosidase. Where indi-
downº program. For SSCP analysis, PCR products (2 ml) were mixedcated, the caspase inhibitor z-VAD-fmk (25 mM) was added 6 hr
with 4 ml sequencing loading buffer, denatured, and separated onposttransfection. After 48 hr, cells were washed with phosphate-
Genphor electrophoresis system (Pharmacia-Amersham, Amer-buffered saline (PBS), fixed with 0.5% glutaraldehyde, washed again
sham, UK) under 15 W constant power for 2 to 3 hr at 58C and thenin PBS, and stained with X-gal (50 mM Tris HCl [pH 8], 2.5 mM
visualized by silver staining. In some cases, the abnormal bandspotassium ferriferrocyanide, 15 mM NaCl, 1 mM MgCl2, 0.5 mg/ml
were excised from the gel and reamplified prior to sequencing inX-gal) for 4 hr. At least 300 b-galactosidase-positive cells were
both directions.counted for each transfection (n 5 3) and identified morphologically
as apoptotic or nonapoptotic.
Bcl10 cDNA and Genomic DNA Sequencing
NF-kB Reporter Assay The Bcl10 ORF was amplified from reverse-transcribed poly(A1)
293 cells were cotransfected in phenol-free DMEM with 1 mg (except RNA using primers 59-GGACCCGGAAGAAGCGCCATCTCC-39 and
where indicated) of expression construct and 0.25 mg of a secreted 59-CATTAAAAATTAAAAGGCAATAAAGTG-39 and cloned into pCR2.1.
placental alkaline phosphatase reporter construct pTK-cSPAP con- In MALT lymphoma case G0186, two separate RT-PCR amplifica-
taining a minimal HSV tyrosine kinase promoter with or without four tions were performed and individual clones sequenced; both reac-
copies of the NF-kB response element GGAAAGTCCC, and 48 hr tions contained wild-type and mutant Bcl10 clones. Sequencing of
posttransfection, 30 ml of medium was removed and heated at 658C the Bcl10-coding region from cell lines and cases with abnormally
for 5 min. To this, 150 ml diethanolamine (DEA) buffer (1 M DEA, 0.28 migrating SSCP bands was performed on amplified or cloned geno-
M NaCl, 0.25 mM MgCl2) containing 7 mM p-nitrophenyl phosphate mic PCR products using dRhodamine DNA polymerase (Perkin-
(PNPP) was added and incubated at 378C for 1 hr. The reaction was Elmer) according to manufacturer instructions.
stopped by adding 75 ml 2 M NaOH, and absorbance was then
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